Olanzapine long-acting injection, discontinuation rates and reasons for discontinuation: 10 years' experience at a UK high-secure hospital. (2022)
Attributed to:
PsySTAR Programme (Psychiatry: Scottish Training in Academic Research Programme)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1177/20451253221113093
PubMed Identifier: 35874556
Publication URI: http://europepmc.org/abstract/MED/35874556
Type: Journal Article/Review
Volume: 12
Parent Publication: Therapeutic advances in psychopharmacology
ISSN: 2045-1253